DIC Healthcare

DIC Healthcare is a specialized subsidiary of the DIC Corporation, focusing on the development and commercialization of diagnostic reagents and medical devices. The company leverages the DIC Group's extensive expertise in fine chemicals and organic synthesis to provide high-quality clinical testing solutions, particularly in the areas of blood analysis and immunology. Its product portfolio primarily includes reagents for measuring critical biomarkers such as C-reactive protein and hemoglobin A1c, which are essential for monitoring inflammation and diabetes. Additionally, the company is closely integrated with the DIC Group's leadership in algae-based biotechnology, supporting the global distribution of Spirulina-derived nutritional products. DIC Healthcare operates with a commitment to precision and reliability, serving hospitals and clinical laboratories primarily in the Japanese market while contributing to global health through its parent's international network.